Impact of obesity on liver function tests: is nonalcoholic fatty liver disease the only player? A review article
Open Access
- 1 September 2023
- journal article
- review article
- Published by Wolters Kluwer Health in Porto Biomedical Journal
- Vol. 8 (5) , e228
Abstract
Objectives: Obesity and nonalcoholic fatty liver disease (NAFLD) are common worldwide health problems with a strong relationship in between. NAFLD is currently the most common cause of abnormal liver function tests (LFT) because of obesity pandemic. The question is NAFLD the only player of abnormal LFT in obesity? Methodology: This article reviews the most important topics regarding the derangements of LFT in obesity through a PubMed search strategy for all English-language literature. Results: The reported abnormal LFT in obesity were increased serum levels of transaminases (alanine aminotransaminase, aspartate aminotransaminase), gamma glutamyl transferase, and alkaline phosphatase and decreased serum levels of bilirubin and albumin. Besides novel potential hepatic markers of NAFLD/NASH such as triglycerides/high-density lipoprotein cholesterol ratio, sex hormone–binding globulin, fibroblast growth factor 21, and markers of hepatocyte apoptosis i.e. cytokeratin 18 and microribonucleic acids (miRNAs). Beyond NAFLD, there are other underlying players for the abnormal LFT in obesity such as oxidative stress, inflammation, and insulin resistance. Conclusion: Derangements of LFT in obesity are attributed to NAFLD but also to obesity itself and its related oxidative stress, insulin resistance, and chronic inflammatory state. Abnormal LFT predict more than just liver disease.Keywords
This publication has 121 references indexed in Scilit:
- The Role of Bilirubin in Diabetes, Metabolic Syndrome, and Cardiovascular DiseasesFrontiers in Pharmacology, 2012
- Serum bilirubin levels are inversely associated with nonalcoholic fatty liver diseaseClinical and Molecular Hepatology, 2012
- Serum Ferritin Is An Independent Predictor of Histologic Severity and Advanced Fibrosis in Patients With Nonalcoholic Fatty Liver DiseaseHepatology, 2011
- Increased very low density lipoprotein (VLDL) secretion, hepatic steatosis, and insulin resistanceTrends in Endocrinology & Metabolism, 2011
- Obesity, Visceral Fat, and NAFLD: Querying the Role of Adipokines in the Progression of Nonalcoholic Fatty Liver DiseaseISRN Gastroenterology, 2011
- Newborn Jaundice Technologies: Unbound Bilirubin and Bilirubin Binding Capacity in NeonatesSeminars in Perinatology, 2011
- An apoptosis panel for nonalcoholic steatohepatitis diagnosisJournal of Hepatology, 2011
- Liver Enzymes Are Associated With Hepatic Insulin Resistance, Insulin Secretion, and Glucagon Concentration in Healthy Men and WomenDiabetes, 2011
- Longitudinal Change in Serum Gamma-Glutamyltransferase and Cardiovascular Disease MortalityArteriosclerosis, Thrombosis, and Vascular Biology, 2008
- Development of a simple noninvasive index to predict significant fibrosis in patients with HIV/HCV coinfectionHepatology, 2006